IVOSIDENIB AND BEVACIZUMAB IN HEAVILY PRETREATED PATIENTS WITH IDH1 MUTANT GLIOMAS

被引：0
|
作者：
Patel, Mallika P. [1 ]
Ziv, Michal Nisnboym [1 ]
Minor, Maria [1 ]
Johnson, Margaret O. [1 ]
Batich, Kristen [1 ]
Low, Justin [1 ]
Shoaf, Madison L. [1 ]
Khasraw, Mustafa [1 ]
Friedman, Henry S. [1 ]
Ashley, David M. [1 ]
Desjardins, Annick [1 ]
Peters, Katherine B. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0670
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
INNV-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS
    Minor, Maria
    Ziv, Michal Nisnboym
    Patel, Mallika
    Johnson, Margaret
    Batich, Kristen
    Low, Justin
    Shoaf, Madison
    Khasraw, Mustafa
    Desjardins, Annick
    Friedman, Henry
    Ashley, David
    Peters, Katherine
    NEURO-ONCOLOGY, 2024, 26
  • [2] Ivosidenib for IDH1 Mutant Cholangiocarcinoma: A Narrative Review
    Sumbly, Vikram
    Landry, Ian
    Rizzo, Vincent
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [3] Mutant IDH1 and thrombosis in gliomas
    Dusten Unruh
    Steven R. Schwarze
    Laith Khoury
    Cheddhi Thomas
    Meijing Wu
    Li Chen
    Rui Chen
    Yinxing Liu
    Margaret A. Schwartz
    Christina Amidei
    Priya Kumthekar
    Carolina G. Benjamin
    Kristine Song
    Caleb Dawson
    Joanne M. Rispoli
    Girish Fatterpekar
    John G. Golfinos
    Douglas Kondziolka
    Matthias Karajannis
    Donato Pacione
    David Zagzag
    Thomas McIntyre
    Matija Snuderl
    Craig Horbinski
    Acta Neuropathologica, 2016, 132 : 917 - 930
  • [4] Mutant IDH1 and thrombosis in gliomas
    Unruh, Dusten
    Schwarze, Steven R.
    Khoury, Laith
    Thomas, Cheddhi
    Wu, Meijing
    Chen, Li
    Chen, Rui
    Liu, Yinxing
    Schwartz, Margaret A.
    Amidei, Christina
    Kumthekar, Priya
    Benjamin, Carolina G.
    Song, Kristine
    Dawson, Caleb
    Rispoli, Joanne M.
    Fatterpekar, Girish
    Golfinos, John G.
    Kondziolka, Douglas
    Karajannis, Matthias
    Pacione, Donato
    Zagzag, David
    McIntyre, Thomas
    Snuderl, Matija
    Horbinski, Craig
    ACTA NEUROPATHOLOGICA, 2016, 132 (06) : 917 - 930
  • [5] Retrospective study of ivosidenib for patients with recurrent IDH mutant gliomas
    El-Ghoubaira, Joseph
    Drappatz, Jan
    Mantica, Megan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Mutant IDH1 Prevents Thrombosis in Gliomas
    Horbinski, Craig
    Schwarze, Steven
    Khoury, Laith
    Thomas, Cheddhi
    Benjamin, Carolina
    Chen, Rui
    Dawson, Caleb
    Liu, Yinxing
    Song, Kristine
    Pacione, Donato
    Zagzag, David
    McIntyre, Thomas
    Snuderl, Matija
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 590 - 590
  • [7] Mutant IDH1 and tissue factor in gliomas
    Unruh, Dusten
    Mirkov, Snezana
    James, Charles D.
    Horbinski, Craig
    CANCER RESEARCH, 2017, 77
  • [8] REAL-WORLD ASSESSMENT OF IDH1 INHIBITOR IVOSIDENIB IN IDH MUTANT LOWER GRADE GLIOMAS - THE JOHNS HOPKINS EXPERIENCE
    Puri, Sushant
    Shi, Jessica
    Blair, Lindsay
    Blakeley, Jaishri
    Laterra, John
    Kamson, David
    NEURO-ONCOLOGY, 2022, 24 : 181 - 181
  • [9] RADIOGRAPHIC RESPONSE AND SEIZURE CONTROL IN IDH1 MUTANT GLIOMA PATIENTS USING IVOSIDENIB
    Peters, Katherine
    Patel, Mallika
    Alford, Candice
    Chavez, Gerardo
    Kim, Jung-Young
    Durling, Jennifer
    Novack, Tracy
    Batich, Kristen
    Shoaf, Madison
    Hanzlik, Emily
    Affronti, Mary
    Johnson, Margaret
    Landi, Daniel
    Khasraw, Mustafa
    Desjardins, Annick
    Friedman, Henry
    Ashley, David M.
    NEURO-ONCOLOGY, 2021, 23 : 109 - 109
  • [10] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
    Chmielewska, Agnieszka
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290
12345